NSTEMI (Non-ST-segment elevation myocardial infarction)

Find all the latest content on NSTEMI published on this website.

NSTEMI is considered one of the leading causes of morbidity and mortality and its definition and treatment remains challenging requiring specific, adapted responses. Understanding different biomarkers, becoming aware of emerging new agents used in adjunctive pharmacotherapy, keeping abreast of advances in imaging techniques as well as the use of invasive imaging and functional assessment is critical. Tools, devices and techniques, and complications such as different types of vascular access or bleeding risks, can also be found here…

Filtered By
NSTEMI

297 results

Innovations in managing calcified lesions

22 Sep 2023 – From AICT-AsiaPCR 2023

Discover advanced strategies for dealing with challenging calcified lesions in this session: learn how to tackle complex situations, including diffuse and heavily calcified lesions, and discover innovative techniques for addressing angulated calcified lesions in the left anterior descending artery and other vessels.

Innovations in managing calcified lesions

Uncommon complications in NSTEMI

22 Sep 2023 – From AICT-AsiaPCR 2023

Discoversome unforeseen challenges in NSTEMI cases in this session, ranging from managing coronary air embolisms and distinguishing between inflammation and infarction to dealing with coronary aneurysms at the left main coronary artery bifurcation and addressing type 5 coronary perforation. 

Uncommon complications in NSTEMI

Advanced techniques for managing calcified lesions

22 Sep 2023 – From AICT-AsiaPCR 2023

Discover advanced strategies for tackling complex calcified lesions in this session: from innovative approaches like the 'Orbital-shock' technique to managing calcified lesions in patients with previous CABG and in-stent restenosis, and exploring calcium modification strategies tailored to specific cases, these presentations offer valuable insights into simplifying...

Advanced techniques for managing calcified lesions

Advances in STEMI and Stable CAD

22 Sep 2023 – From AICT-AsiaPCR 2023

Explore cutting-edge insights into STEMI and Stable CAD through these presentations: delve into the intricate details of characterizing culprit coronary lesions in STEMI patients using OCT, uncover the short- and long-term outcomes for Asian STEMI patients following primary PCI and gain a comprehensive understanding of the...

Advances in STEMI and Stable CAD

NSTEMI: lessons from real cases

21 Sep 2023 – From AICT-AsiaPCR 2023

Explore real-world cases in this NSTEMI session where experts discuss their experiences in managing challenging scenarios: learn about novel techniques to handle RCA perforations, restore torqued and kinked catheters, and more!

NSTEMI: lessons from real cases

Challenges in calcified lesions

21 Sep 2023 – From AICT-AsiaPCR 2023

Explore a variety of challenging cases in this session, from the perplexing uncrossable STEMI to the specialized "Blocked" balloon anchoring technique, the unique challenges of calcified lesions in elderly patients to the debulking of a calcified nodule within the left circumflex ostium through the stent strut,...

Challenges in calcified lesions

Complex left main scenarios

21 Sep 2023 – From AICT-AsiaPCR 2023

Discover unique insights into these challenging left main scenarios, including anomalous left coronary artery from the pulmonary artery (ALCAPA), guide extension catheter entrapment by a coronary stent, the utility of OCT guidance in complex left main trifurcation PCI, and a rare instance of a young patient with...

Complex left main scenarios

Top abstracts of AICT-AsiaPCR 2023

21 Sep 2023 – From AICT-AsiaPCR 2023

Explore the cutting-edge research showcased in the top abstracts of AICT-AsiaPCR 2023, featuring insights on CT-based valve sizing for TAVR in bicuspid aortic stenosis and the impact of bleeding events post-TAVI on long-term mortality.

Top abstracts of AICT-AsiaPCR 2023

Left main interventions: cutting-edge insights

21 Sep 2023 – From AICT-AsiaPCR 2023

Join us in this session on left main interventions and explore the challenges and strategies for left main PCI in complex cases, from minimalist approaches in limited-resource settings to complex procedures like percutaneous transluminal coronary angioplasty with IVUS guidance.

Left main interventions: cutting-edge insights

2023 ESC Guidelines for the management of acute coronary syndromes

30 Aug 2023

Cardiovascular disease in particular ischaemic heart disease is the leading cause of mortality worldwide. International guidelines provide recommendations on the best evidence-based care for patients. At the ESC Congress 2023 in Amsterdam, the ESC 2023 Guidelines on Acute Coronary Syndromes were presented and published1. Vijay Kunadian provides...

Vijay Kunadian

Author

Vijay Kunadian
2023 ESC Guidelines for the management of acute coronary syndromes

ECLS-SHOCK: venoarterial membrane oxygenation in cardiogenic shock

27 Aug 2023

Panos Xaplanteris & Leonidas Koliastasis provide their take on the final results of the ECLS-SHOCK (Extracorporeal Life Support in Infarct-Related Cardiogenic Shock) which were presented by Holger Thiele during the ESC 2023 congress in Amsterdam.

Panagiotis Xaplanteris

Author

Panagiotis Xaplanteris

Author

Leonidas Koliastasis
ECLS-SHOCK

FIRE trial: physiology-guided complete PCI in older MI patients

27 Aug 2023

Luis Ortega-Paz interviews Simone Biscaglia and Gianluca Campo about the FIRE trial.
Results showed elderly patients presenting with either STEMI or NSTEMI benefit from complete revascularization, reducing cardiovascular events risk at 1 year compared to culprit lesion-only PCI.

Published simultaneously in the New England Journal of Medicine

Luis Ortega-Paz

Author

Luis Ortega-Paz
Simone Biscaglia

Author

Simone Biscaglia
Gianluca Campo

Author

Gianluca Campo
FIRE trial: physiology-guided complete PCI in older MI patient

Impact of alirocumab on plaque regression and haemodynamics of non-culprit arteries in patients with acute myocardial infarction: a prespecified substudy of the PACMAN-AMI trial

12 Jul 2023

This is a trial aiming to assess QFR and 3D-QCA DS% of all the non-infarct related arteries (IRA) with 3D-QCA DS% in all patients presenting with STEMI/NSTEMI and undergoing coronary angiography. 

Dr. Mirvat Alasnag

Reviewer

Mirvat Alasnag

Reviewer

Jamilah AlRahimi
Impact of alirocumab on plaque regression and haemodynamics of non-culprit arteries in patients with acute myocardial infarction: a prespecified substudy of the PACMAN-AMI trial

Percutaneous coronary intervention vs coronary artery bypass graft surgery for left main disease in patients with and without acute coronary syndromes: a pooled analysis of 4 randomized clinical trials

05 Jul 2023

This patient-level analysis of randomized trials comparing PCI vs CABG for the treatment of low-to-intermediate CAD involving the LM confirms the absence of long-term differences in mortality between revascularization techniques, regardless of the clinical presentation.

Giovanni Occhipinti

Reviewer

Giovanni Occhipinti
Daniele Giacoppo

Reviewer

Daniele Giacoppo
PCI vs CABG surgery for LM disease in patients with and without ACS: a pooled analysis of 4 randomized clinical trials

PCI or CABG for left main coronary artery disease: the SWEDEHEART registry

28 Jun 2023

While the choice between PCI and CABG for LMCA disease continues to be one of the most controversial topics, patient characteristics & comorbidities must be taken into account, as must the external validity of the results of RCTs in the real world, as the SWEDEHEART registry does.

Panagiotis Xaplanteris

Reviewer

Panagiotis Xaplanteris

Reviewer

Leonidas Koliastasis
PCI or CABG for left main coronary artery disease: the SWEDEHEART registry

Single antiplatelet therapy directly after percutaneous coronary intervention in non-ST-segment elevation acute coronary syndrome patients: the OPTICA study

24 May 2023

The aim of the current trial was to explore if direct P2Y12 inhibitor monotherapy was feasible and safe in patients with NSTEMI undergoing PCI.

Elad Asher

Reviewer

Elad Asher
Single antiplatelet therapy directly after percutaneous coronary intervention in non-ST-segment elevation acute coronary syndrome patients: the OPTICA study

EuroPCR 2023 Hotlines/Late-Breaking Trials: from (N)STEMI to Chronic Coronary Syndromes (CCS)

19 May 2023 – From EuroPCR 2023

What are the most significant facts in this respect? Get the essentials by listening to the presenters review some clinical hotlines. To cite a few, Selective Intracoronary hypothermia in anterior wall myocardial infarction; real-time catheter-based microvascular obstruction detection in STEMI : results from the MOCCA I...

from (N)STEMI to Chronic Coronary Syndromes (CCS)

PCI complications: stent loss / dissertations / perforations

19 May 2023 – From EuroPCR 2023

Discover the case of an 81-year-old woman with diabetes mellitus type 2 and severe aortic stenosis, who presented with a unique challenge of double coronary artery perforation. With a plan for angioplasty and percutaneous aortic valve implantation, this complex scenario highlights the expertise and multidisciplinary approach required in...

PCI complications: stent loss / dissertations / perforations

ACS - Abstract session

19 May 2023 – From EuroPCR 2023

Looking for a quick review of the Abstract session on acute coronary syndrome (ACS)? Explore the presentation slides available here and catch up on key elements to consider.

STEMI and adjunctive theraphy

18 May 2023 – From EuroPCR 2023

Delve into the world of STEMI and adjunctive therapy in this session: explore the potential impact of antiplatelet therapy on achieving an "optimal" angiographic result, gain insights into the considerations surrounding tirofiban and ticagrelor use during pregnancy and delivery, discover the role of cangrelor in the...

STEMI and adjunctive theraphy